Immunopharmacology of senescence: targeting the senescence-associated secretory phenotype (SASP)—a mechanism-based review

Jul 27, 2025Inflammopharmacology

Immune-related drugs targeting the harmful secretions from aging cells

AI simplified

Abstract

Cellular senescence is a natural process where cells permanently stop dividing, playing a role in cancer prevention and tissue repair.

  • Senescent cells release inflammatory factors that can lead to chronic inflammation and disrupt immune function.
  • The interaction between the immune system and senescent cells influences whether these cells are cleared or become harmful.
  • Immunopharmacology explores how drugs can modify immune responses to target the harmful effects of senescent cells.
  • Recent research highlights potential therapies aimed at removing senescent cells or altering their secretions to mitigate health issues.
  • Developing therapies that target the senescence-associated secretory phenotype (SASP) may help improve health and address age-related diseases.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free